Schizophrenia trials recruiting in Alabama

All Schizophrenia trials nationally

Cities in Alabama

Recruiting trials in Alabama

• A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively
  NCT07424404 · Phase: Phase 3 · Ages: 5 Years to 17 Years · Sex: All (male and female) · Alabama: Dothan
• Activities to Change Your Mood: A Test of the Acceptability and Initial Efficacy in Clinical Samples and Healthy Controls
  NCT06911723 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · Alabama: Birmingham
• Biomarkers to Enhance Early Schizophrenia Treatment
  NCT06969755 · Phase: Phase 4 · Ages: 18 Years to 35 Years · Sex: All (male and female) · Alabama: Birmingham
• Determining the Role of Social Reward Learning in Social Anhedonia
  NCT05617898 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 35 Years · Sex: All (male and female) · Alabama: Birmingham
• Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
  NCT05303064 · Phase: Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female) · Alabama: Dothan